The end of the COVID-19 sales opportunity was clearly visible in Medtech Insight’s latest annual listing of the top 100 global medtech players by revenues for 2023.
Medtech Insight’s Latest Medtech 100 Ranking Published
Medtronic Powers Back To Lead Global All-Medtech Ranking And Fast-Growing China Medtechs Enter Top 100
Top 100 publicly listed medtech companies ranked by global revenues, and listings for the top cardiology, orthopedic, IVD and imaging performers based on 2023 or 2023-24 revenues, are now available from Medtech Insight.
More from Company Rankings
More from Medtech Insight
• By
Cambridge, UK-based breath biopsy company Owlstone Medical will apply its volatile organic compound analysis platform in an attempt to develop a test for the identification and monitoring of pseudomonas aeruginosa in patients with cystic fibrosis.
The Doctor Patient Forum says the US FDA should regulate a scoring platform from Bamboo Health intended to help clinicians calculate risk for opioid abuse as a medical device to ensure patient safety.
• By
The urine-based GAGome test showed promise in the first clinical results from the international AURORAX-0087A, in the largest study conducted on clear cell renal cell carcinoma, the most common type of kidney cancer.